Forte Biosciences Newsroom

Forte Biosciences Is Maintained at Buy by Chardan Capital

Dow JonesNov 16 06:36

Forte Biosciences Analyst Ratings

BenzingaNov 16 06:22

Forte Biosciences Analyst Ratings

BenzingaAug 19 20:34

Chardan Capital Maintains Buy on Forte Biosciences, Maintains $3 Price Target

BenzingaAug 19 20:34

Forte Biosciences Analyst Ratings

BenzingaMay 30 18:00

Brookline Capital Initiates Coverage On Forte Biosciences With Buy Rating, Announces Price Target of $4

BenzingaMay 30 18:00

Ladenburg Thalmann: Upgraded Forte Biosciences (FBRX.US) rating from neutral to buy, with a target price of $2.75.

Zhitong FinanceApr 9 05:40

Forte Biosciences Analyst Ratings

BenzingaApr 9 05:40